The extracellular domain targets a membrane antigen expressed at the surface of targeted cells such as CD19 for lymphoid malignancies (ALL, non-Hodgkin’s lymphoma, etc.)or B Cell Maturation Antigen (BCMA) expressed on malignant plasma cells in patients affected with multiple myeloma. This evidence concerns the gene TNFRSF17 and AL amyloidosis.